|
US4307016A
(en)
|
1978-03-24 |
1981-12-22 |
Takeda Chemical Industries, Ltd. |
Demethyl maytansinoids
|
|
US4256746A
(en)
|
1978-11-14 |
1981-03-17 |
Takeda Chemical Industries |
Dechloromaytansinoids, their pharmaceutical compositions and method of use
|
|
JPS55102583A
(en)
|
1979-01-31 |
1980-08-05 |
Takeda Chem Ind Ltd |
20-acyloxy-20-demethylmaytansinoid compound
|
|
JPS55162791A
(en)
|
1979-06-05 |
1980-12-18 |
Takeda Chem Ind Ltd |
Antibiotic c-15003pnd and its preparation
|
|
JPS5645483A
(en)
|
1979-09-19 |
1981-04-25 |
Takeda Chem Ind Ltd |
C-15003phm and its preparation
|
|
EP0028683A1
(en)
|
1979-09-21 |
1981-05-20 |
Takeda Chemical Industries, Ltd. |
Antibiotic C-15003 PHO and production thereof
|
|
JPS5645485A
(en)
|
1979-09-21 |
1981-04-25 |
Takeda Chem Ind Ltd |
Production of c-15003pnd
|
|
WO1982001188A1
(en)
|
1980-10-08 |
1982-04-15 |
Takeda Chemical Industries Ltd |
4,5-deoxymaytansinoide compounds and process for preparing same
|
|
US4450254A
(en)
|
1980-11-03 |
1984-05-22 |
Standard Oil Company |
Impact improvement of high nitrile resins
|
|
US4315929A
(en)
|
1981-01-27 |
1982-02-16 |
The United States Of America As Represented By The Secretary Of Agriculture |
Method of controlling the European corn borer with trewiasine
|
|
US4313946A
(en)
|
1981-01-27 |
1982-02-02 |
The United States Of America As Represented By The Secretary Of Agriculture |
Chemotherapeutically active maytansinoids from Trewia nudiflora
|
|
US4563304A
(en)
|
1981-02-27 |
1986-01-07 |
Pharmacia Fine Chemicals Ab |
Pyridine compounds modifying proteins, polypeptides or polysaccharides
|
|
JPS57192389A
(en)
|
1981-05-20 |
1982-11-26 |
Takeda Chem Ind Ltd |
Novel maytansinoid
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
WO1989006692A1
(en)
|
1988-01-12 |
1989-07-27 |
Genentech, Inc. |
Method of treating tumor cells by inhibiting growth factor receptor function
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US20030229208A1
(en)
|
1988-12-28 |
2003-12-11 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US6172197B1
(en)
|
1991-07-10 |
2001-01-09 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
US6916605B1
(en)
|
1990-07-10 |
2005-07-12 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
CA2089661C
(en)
|
1990-08-29 |
2007-04-03 |
Nils Lonberg |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
WO1992009690A2
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with altered binding properties
|
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
ES2227512T3
(es)
|
1991-12-02 |
2005-04-01 |
Medical Research Council |
Produccion de anticuerpos contra auto-antigenos a partir de repertorios de segmentos de anticuerpos fijados en un fago.
|
|
WO1993017715A1
(en)
|
1992-03-05 |
1993-09-16 |
Board Of Regents, The University Of Texas System |
Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells
|
|
US5965132A
(en)
|
1992-03-05 |
1999-10-12 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
|
US20030148406A1
(en)
|
1992-03-17 |
2003-08-07 |
David John King |
Multivalent antigen-binding proteins
|
|
DE69231123T2
(de)
|
1992-03-25 |
2001-02-15 |
Immunogen Inc |
Konjugaten von Zell-bindender Mittel und Derivaten von CC-1065
|
|
EP0714409A1
(en)
|
1993-06-16 |
1996-06-05 |
Celltech Therapeutics Limited |
Antibodies
|
|
US6706484B1
(en)
|
1995-08-18 |
2004-03-16 |
Morphosys Ag |
Protein/(poly)peptide libraries
|
|
CA2229043C
(en)
|
1995-08-18 |
2016-06-07 |
Morphosys Gesellschaft Fur Proteinoptimierung Mbh |
Protein/(poly)peptide libraries
|
|
WO1997011971A1
(en)
|
1995-09-28 |
1997-04-03 |
Alexion Pharmaceuticals, Inc. |
Porcine cell interaction proteins
|
|
US6596850B1
(en)
|
1998-01-30 |
2003-07-22 |
Ixsys, Incorporated |
Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same
|
|
US20070059302A1
(en)
|
1997-04-07 |
2007-03-15 |
Genentech, Inc. |
Anti-vegf antibodies
|
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
DK1325932T5
(da)
|
1997-04-07 |
2005-10-03 |
Genentech Inc |
Anti-VEGF antistoffer
|
|
US20020032315A1
(en)
|
1997-08-06 |
2002-03-14 |
Manuel Baca |
Anti-vegf antibodies
|
|
WO2000023082A1
(en)
|
1998-10-19 |
2000-04-27 |
Yeda Research And Development Co. Ltd. |
Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens
|
|
US20040031072A1
(en)
|
1999-05-06 |
2004-02-12 |
La Rosa Thomas J. |
Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
|
|
DE60044997D1
(de)
|
1999-07-02 |
2010-11-04 |
Morphosys Ag |
Erzeugung spezifischer bindungspartner die an von genomischen dns-fragmenten oder ests kodierten (poly)peptiden binden
|
|
IT1307309B1
(it)
|
1999-12-30 |
2001-10-30 |
Enea Ente Nuove Tec |
Peptidi stabilizzanti, polipeptidi ed anticorpi che li comprendono.
|
|
AU2001256970C1
(en)
|
2000-03-31 |
2008-07-03 |
Purdue Research Foundation |
Method of treatment using ligand-immunogen conjugates
|
|
DE10037759A1
(de)
|
2000-08-03 |
2002-07-04 |
Gruenenthal Gmbh |
Screeningverfahren
|
|
US6333410B1
(en)
|
2000-08-18 |
2001-12-25 |
Immunogen, Inc. |
Process for the preparation and purification of thiol-containing maytansinoids
|
|
MXPA03007316A
(es)
|
2001-02-19 |
2003-12-04 |
Merck Patent Gmbh |
Metodo para la identificacion de epitopes de celulas t y el uso para la preparacion de moleculas con inmunogenicidad reducida.
|
|
US20030087250A1
(en)
|
2001-03-14 |
2003-05-08 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
|
RU2316349C2
(ru)
|
2001-05-02 |
2008-02-10 |
Пердью Рисерч Фаундейшн |
Лечение и диагностика заболеваний, опосредованных макрофагами
|
|
US6441163B1
(en)
|
2001-05-31 |
2002-08-27 |
Immunogen, Inc. |
Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
|
|
US6716821B2
(en)
|
2001-12-21 |
2004-04-06 |
Immunogen Inc. |
Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
|
|
US7314974B2
(en)
|
2002-02-21 |
2008-01-01 |
Monsanto Technology, Llc |
Expression of microbial proteins in plants for production of plants with improved properties
|
|
WO2003074704A1
(fr)
|
2002-03-01 |
2003-09-12 |
Japan Envirochemicals, Ltd. |
Proteines capables de se lier aux hormones sexuelles feminines et procede de preparation
|
|
NZ535425A
(en)
|
2002-03-13 |
2008-05-30 |
Biogen Idec Inc |
Anti-alphavbeta6 antibodies
|
|
AU2003224073C1
(en)
|
2002-04-22 |
2010-03-11 |
AgroProtect GmbH |
Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi
|
|
AU2003295411A1
(en)
|
2002-11-07 |
2004-06-03 |
Celltech R & D |
Human monoclonal antibodies to heparanase
|
|
EP1481993A1
(en)
|
2003-05-28 |
2004-12-01 |
Xerion Pharmaceuticals AG |
Modulation of the poliovirus receptor function
|
|
US20080131366A1
(en)
|
2003-03-17 |
2008-06-05 |
Manohar Ratnam |
Folate Receptor Gene Modulation For Cancer Diagnosis And Therapy
|
|
US20050255114A1
(en)
|
2003-04-07 |
2005-11-17 |
Nuvelo, Inc. |
Methods and diagnosis for the treatment of preeclampsia
|
|
US20050025763A1
(en)
|
2003-05-08 |
2005-02-03 |
Protein Design Laboratories, Inc. |
Therapeutic use of anti-CS1 antibodies
|
|
WO2005000901A2
(en)
|
2003-05-09 |
2005-01-06 |
Duke University |
Cd20-specific antibodies and methods of employing same
|
|
US8088387B2
(en)
|
2003-10-10 |
2012-01-03 |
Immunogen Inc. |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
|
|
CN1816356A
(zh)
|
2003-05-14 |
2006-08-09 |
免疫原公司 |
药物缀合物组合物
|
|
US7276497B2
(en)
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
MXPA05012723A
(es)
|
2003-05-30 |
2006-02-08 |
Genentech Inc |
Tratamiento con anticuerpos anti-vgf.
|
|
CA2530393A1
(en)
|
2003-07-02 |
2005-01-13 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
US7622112B2
(en)
|
2003-12-05 |
2009-11-24 |
Jody Berry |
Anti-SARS monoclonal antibodies
|
|
US20050232919A1
(en)
|
2004-02-12 |
2005-10-20 |
Morphotek, Inc. |
Monoclonal antibodies that specifically block biological activity of a tumor antigen
|
|
EP2214018B1
(en)
|
2004-04-27 |
2013-06-26 |
Galapagos N.V. |
Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
|
|
AU2005279347A1
(en)
|
2004-08-30 |
2006-03-09 |
Lonza Biologics Plc. |
Affinity- plus ion exchange- chromatography for purifying antibodies
|
|
US8772269B2
(en)
|
2004-09-13 |
2014-07-08 |
Eisai R&D Management Co., Ltd. |
Use of sulfonamide-including compounds in combination with angiogenesis inhibitors
|
|
US7776869B2
(en)
|
2004-10-18 |
2010-08-17 |
Amgen Inc. |
Heteroaryl-substituted alkyne compounds and method of use
|
|
NZ554725A
(en)
|
2004-10-25 |
2009-10-30 |
Merck & Co Inc |
Anti-ADDL antibodies and uses thereof
|
|
US20070294782A1
(en)
|
2004-12-21 |
2007-12-20 |
Mark Abad |
Transgenic plants with enhanced agronomic traits
|
|
US20090087478A1
(en)
|
2004-12-27 |
2009-04-02 |
Progenics Pharmaceuticals (Nevada), Inc. |
Orally Deliverable and Anti-Toxin Antibodies and Methods for Making and Using Them
|
|
MX2007008017A
(es)
|
2004-12-31 |
2007-09-12 |
Genentech Inc |
Polipeptidos que se ligan a br3 y usos de los mismos.
|
|
WO2007094754A2
(en)
|
2005-01-27 |
2007-08-23 |
The Regents Of The University Of Califordnia |
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
|
|
CN101232901B
(zh)
*
|
2005-02-28 |
2011-12-07 |
卫材R&D管理有限公司 |
磺酰胺化合物和血管生成抑制物质的联合新应用
|
|
DK1866339T3
(da)
|
2005-03-25 |
2013-09-02 |
Gitr Inc |
GTR-bindende molekyler og anvendelser heraf
|
|
US7608413B1
(en)
|
2005-03-25 |
2009-10-27 |
Celera Corporation |
Kidney disease targets and uses thereof
|
|
EP1864133B1
(en)
|
2005-03-30 |
2010-03-10 |
Purdue Research Foundation |
Method for breastcancer prognosis using cellular folate vitamin receptor quantification
|
|
US20060239910A1
(en)
|
2005-04-22 |
2006-10-26 |
Morphotek Inc. |
Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells
|
|
US7786266B2
(en)
|
2005-05-12 |
2010-08-31 |
Oncotherapy Science, Inc. |
Methods for damaging cells using effector function of anti-DSC2 antibody
|
|
CA2606576A1
(en)
|
2005-05-20 |
2006-11-23 |
Lonza Biologics Plc. |
High-level expression of recombinant antibody in a mammalian host cell
|
|
CN101273063A
(zh)
|
2005-05-24 |
2008-09-24 |
阿维斯塔金格兰技术有限公司 |
用于b细胞淋巴瘤治疗的针对cd20的单克隆抗体的生产方法
|
|
EP1904183B1
(en)
|
2005-07-05 |
2014-10-15 |
Purdue Research Foundation |
Pharmaceutical composition for the treatment of osteoarthritis
|
|
US7521195B1
(en)
|
2005-07-21 |
2009-04-21 |
Celera Corporation |
Lung disease targets and uses thereof
|
|
EP1937720B1
(en)
|
2005-08-18 |
2014-04-09 |
Ramot at Tel-Aviv University Ltd. |
Single chain antibodies against beta-amyloid peptide
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
JP4938263B2
(ja)
|
2005-08-19 |
2012-05-23 |
独立行政法人農業生物資源研究所 |
一本鎖抗体によるサイトゾルタンパク質の機能阻害法およびその利用
|
|
SG165322A1
(en)
|
2005-08-31 |
2010-10-28 |
Schering Corp |
Engineered anti-il-23 antibodies
|
|
US8044179B2
(en)
|
2005-09-13 |
2011-10-25 |
National Research Council Of Canada |
Methods and compositions for modulating tumor cell activity
|
|
EP1937307A4
(en)
*
|
2005-09-14 |
2009-05-13 |
Hutchinson Fred Cancer Res |
SPECIFIC REMOVAL OF ACTIVATED IMMUNOCELLS
|
|
US20070099251A1
(en)
|
2005-10-17 |
2007-05-03 |
Institute For Systems Biology |
Tissue-and serum-derived glycoproteins and methods of their use
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
SI2532681T1
(sl)
|
2005-12-20 |
2015-03-31 |
Sbi Biotech Co., Ltd. |
Protitelo proti-ILT7
|
|
WO2007109747A2
(en)
|
2006-03-21 |
2007-09-27 |
Wyeth |
Methods and compositions for antagonism of rage
|
|
WO2007143561A1
(en)
|
2006-06-01 |
2007-12-13 |
Mayo Foundation For Medical Education And Research |
Immunity to folate receptors
|
|
ZA200809100B
(en)
*
|
2006-06-06 |
2009-12-30 |
Genentech Inc |
Anti-DLL4 antibodies and methods using same
|
|
DK2032701T3
(da)
|
2006-06-23 |
2014-02-10 |
Alethia Biotherapeutics Inc |
Polynukleotider og polypeptider, der er inddraget i cancer
|
|
US7910702B2
(en)
|
2006-07-28 |
2011-03-22 |
The Governors Of The University Of Alberta |
Recombinant antibodies to sclerotinia antigens
|
|
AU2007284651B2
(en)
|
2006-08-09 |
2014-03-20 |
Institute For Systems Biology |
Organ-specific proteins and methods of their use
|
|
ES2902063T3
(es)
|
2006-09-08 |
2022-03-24 |
Abbvie Bahamas Ltd |
Proteínas de unión a interleucina-13
|
|
EP1900752A1
(en)
|
2006-09-15 |
2008-03-19 |
DOMPE' pha.r.ma s.p.a. |
Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma
|
|
MY162056A
(en)
|
2006-10-12 |
2017-05-31 |
Univ Tokyo |
Diagnosis and treatment of cancer using anti -ereg antibody
|
|
AU2007325838B2
(en)
*
|
2006-11-22 |
2013-09-19 |
Bristol-Myers Squibb Company |
Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
|
|
EP2103628A4
(en)
|
2006-12-14 |
2012-02-22 |
Forerunner Pharma Res Co Ltd |
MONOCLONAL ANTIBODY ANTI-CLAUDIN 3, AND TREATMENT AND DIAGNOSIS OF CANCER USING SUCH ANTIBODY
|
|
CN101675074B
(zh)
|
2006-12-20 |
2016-02-24 |
Mmr全球公司 |
抗体及其制备和使用方法
|
|
US20080227704A1
(en)
|
2006-12-21 |
2008-09-18 |
Kamens Joanne S |
CXCL13 binding proteins
|
|
US7691980B2
(en)
|
2007-01-09 |
2010-04-06 |
Bio-Rad Laboratories, Inc. |
Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
|
|
EP2129402A2
(en)
|
2007-02-16 |
2009-12-09 |
KTB Tumorforschungsgesellschaft mbH |
Receptor and antigen targeted prodrug
|
|
WO2008101231A2
(en)
|
2007-02-16 |
2008-08-21 |
Endocyte, Inc. |
Methods and compositions for treating and diagnosing kidney disease
|
|
US20100111966A1
(en)
|
2007-02-23 |
2010-05-06 |
Schering Corporation |
Engineered anti-il-23p19 antibodies
|
|
WO2008145136A1
(en)
|
2007-05-30 |
2008-12-04 |
Aarhus Universitet |
Stat3 inactivation by inhibition of the folate receptor pathway
|
|
WO2009002993A1
(en)
|
2007-06-25 |
2008-12-31 |
Endocyte, Inc. |
Conjugates containing hydrophilic spacer linkers
|
|
CN101139613B
(zh)
|
2007-08-01 |
2011-06-08 |
姜荣锡 |
抗肿瘤二元多肽及其应用与制备方法
|
|
TWI580694B
(zh)
*
|
2007-11-30 |
2017-05-01 |
建南德克公司 |
抗-ｖｅｇｆ抗體
|
|
US20110038867A1
(en)
|
2007-12-12 |
2011-02-17 |
Carlo Pincelli |
Remedies for pemphigus containing anti fas ligand antibodies
|
|
CN101903526B
(zh)
|
2007-12-21 |
2014-02-12 |
诺华股份有限公司 |
有机化合物
|
|
MX2010007102A
(es)
|
2007-12-26 |
2011-07-01 |
Biotest Ag |
Inmunoconjugados dirigidos contra cd138 y sus usos.
|
|
SG187457A1
(en)
|
2008-01-11 |
2013-02-28 |
Univ Tokyo |
Anti-cldn6 antibody
|
|
WO2009092014A1
(en)
|
2008-01-18 |
2009-07-23 |
Gagnon Peter S |
Enhanced purification of antibodies and antibody fragments by apatite chromatography
|
|
WO2009094456A2
(en)
*
|
2008-01-22 |
2009-07-30 |
Johns Hopkins University |
Use of high-dose, post-transplantation oxazaphosphorine drugs for reduction of transplant rejection
|
|
WO2009132081A2
(en)
|
2008-04-24 |
2009-10-29 |
The Research Foundation Of State University Of New York |
Monoclonal antibody-based targeting of folate receptors
|
|
BRPI0911442A2
(pt)
|
2008-04-30 |
2019-03-12 |
Immunogen, Inc. |
conjugados potentes e ligantes hidrofílicos
|
|
KR101764927B1
(ko)
|
2008-04-30 |
2017-08-03 |
이뮤노젠 아이엔씨 |
가교제 및 그 용도
|
|
US8383351B2
(en)
|
2008-06-11 |
2013-02-26 |
Oxford Brookes University |
Antibody to inhibin/ activin β-B subunit
|
|
JP5675619B2
(ja)
|
2008-09-17 |
2015-02-25 |
エンドサイト, インク.Endocyte, Inc. |
葉酸拮抗薬の葉酸受容体結合性コンジュゲート
|
|
US20100092470A1
(en)
|
2008-09-22 |
2010-04-15 |
Icb International, Inc. |
Antibodies, analogs and uses thereof
|
|
CN101440130B
(zh)
|
2008-11-21 |
2011-07-27 |
中国人民解放军第四军医大学 |
一种抗人IL-13Rα2单克隆抗体的重链和轻链的可变区
|
|
RS58566B1
(sr)
|
2008-12-19 |
2019-05-31 |
Medicis Pharmaceutical Corp |
Formulacije imikuimoda niže dozne jačine i kratkih režima doziranja za lečenje aktinične keratoze
|
|
EP2995953B1
(en)
|
2009-03-24 |
2017-11-29 |
Biocept, Inc. |
Devices and methods of cell capture and analysis
|
|
DK2462161T3
(en)
|
2009-08-06 |
2017-06-06 |
Immunas Pharma Inc |
Antibodies specifically binding to A-beta oligomers and their use
|
|
CN102686611A
(zh)
|
2009-10-09 |
2012-09-19 |
赛诺菲 |
与“渐进性糖化终产物受体”结合的多肽以及包括所述多肽的组合物和方法
|
|
AU2011207362B2
(en)
*
|
2010-01-21 |
2013-10-17 |
Immunogen, Inc. |
Compositions and methods for treatment of ovarian cancer
|
|
US9175086B2
(en)
|
2010-02-10 |
2015-11-03 |
Immunogen, Inc. |
CD20 antibodies and uses thereof
|
|
SG183414A1
(en)
*
|
2010-02-23 |
2012-09-27 |
Genentech Inc |
Anti-angiogenesis therapy for the treatment of ovarian cancer
|
|
TWI796132B
(zh)
|
2010-02-24 |
2023-03-11 |
美商免疫遺傳股份有限公司 |
葉酸受體１抗體類和免疫共軛物類及彼等之用途
|
|
EP2550295A1
(en)
|
2010-03-24 |
2013-01-30 |
F. Hoffmann-La Roche AG |
Anti-lrp6 antibodies
|
|
JP2013523843A
(ja)
*
|
2010-04-15 |
2013-06-17 |
ベジェニクス ピーティーワイ リミテッド |
Ｖｅｇｆ−ｃ拮抗剤を用いた併用治療
|
|
US20120164137A1
(en)
|
2010-10-20 |
2012-06-28 |
Morphotek, Inc. |
Anti-folate receptor alpha antibody glycoforms
|
|
RU2630608C2
(ru)
|
2010-11-05 |
2017-09-11 |
Морфотек Инк. |
Рецептор фолиевой кислоты альфа в качестве диагностического и прогностического маркера злокачественных опухолей, экспрессирующих рецептор фолиевой кислоты альфа
|
|
AU2012209184B2
(en)
*
|
2011-01-26 |
2017-06-15 |
Allergan, Inc. |
Androgen composition for treating an opthalmic condition
|
|
AU2012236403B2
(en)
|
2011-03-29 |
2016-08-04 |
Immunogen, Inc. |
Process for manufacturing conjugates of improved homogeneity
|
|
RS58367B1
(sr)
|
2011-03-29 |
2019-03-29 |
Immunogen Inc |
Priprema konjugata antitela i majtanzinoida jednostepenim postupkom
|
|
HRP20180358T1
(hr)
|
2011-04-01 |
2018-04-06 |
Immunogen, Inc. |
Postupci povećavanja djelotvornosti terapije raka usmjerene protiv folr1
|
|
WO2012138749A1
(en)
|
2011-04-04 |
2012-10-11 |
Immunogen, Inc. |
Methods for decreasing ocular toxicity of antibody drug conjugates
|
|
WO2012145112A2
(en)
*
|
2011-04-18 |
2012-10-26 |
Immunogen, Inc. |
Novel maytansinoid derivatives with sulfoxide linker
|
|
EP2524929A1
(en)
|
2011-05-17 |
2012-11-21 |
Sanofi |
Use of anti-CD19 maytansinoid immunoconjugate antibody for the treatment of CD19+ B-cell malignancies syptoms
|
|
CN103998467B
(zh)
|
2011-07-15 |
2016-12-14 |
卫材R&D管理有限公司 |
抗叶酸受体α抗体及其应用
|
|
WO2013185215A1
(en)
|
2012-06-12 |
2013-12-19 |
Amorfix Life Sciences Ltd. |
Antibodies and conjugates that target misfolded prion protein
|
|
US9200073B2
(en)
*
|
2012-08-31 |
2015-12-01 |
Immunogen, Inc. |
Diagnostic assays and kits for detection of folate receptor 1
|
|
WO2014055842A1
(en)
|
2012-10-04 |
2014-04-10 |
Immunogen, Inc. |
Process for preparing stable antibody maytansinoid conjugates
|
|
WO2014087863A1
(ja)
|
2012-12-07 |
2014-06-12 |
協和発酵キリン株式会社 |
抗ｆｏｌｒ１抗体
|
|
US9415118B2
(en)
*
|
2013-03-13 |
2016-08-16 |
Novartis Ag |
Antibody drug conjugates
|
|
US10933032B2
(en)
*
|
2013-04-08 |
2021-03-02 |
Berg Llc |
Methods for the treatment of cancer using coenzyme Q10 combination therapies
|
|
SG11201509043RA
(en)
|
2013-05-14 |
2015-12-30 |
Immunogen Inc |
Anti-folr1 immunoconjugate dosing regimens
|
|
US20160311921A1
(en)
*
|
2013-06-20 |
2016-10-27 |
Morphotek ,Inc. |
Methods for treatment of ovarian cancer
|
|
ES2883191T3
(es)
|
2013-08-30 |
2021-12-07 |
Immunogen Inc |
Anticuerpos y ensayos para la detección del receptor 1 de folato
|
|
LT3055332T
(lt)
*
|
2013-10-08 |
2020-04-10 |
Immunogen, Inc. |
Anti-folr1 imunokonjugato dozavimo režimai
|
|
US20150297744A1
(en)
|
2014-03-28 |
2015-10-22 |
Immunogen, Inc. |
Anti-FOLR1 Immunoconjugate Dosing Regimens
|
|
HK1255141A1
(zh)
|
2015-09-17 |
2019-08-09 |
伊缪诺金公司 |
包含抗folr1免疫缀合物的治疗组合
|